Abstract:A low cytotoxicity and high efficiency delivery system with the advantages of low cost and facile fabrication is needed for the application of small interfering RNA (siRNA) delivery both in vitro and in vivo. For these prerequisites, cationic polymer-mesoporous silica nanoparticles (ssCP-MSNs) were prepared by surface functionalized mesoporous silica nanoparticles with disulfide bond cross-linked poly(2-dimethylaminoethyl methacrylate) (PDMAEMA). In vitro and in vivo evaluations were performed. The synthesized ssCP-MSNs are 100-150 nm in diameter with a pore size of 10 nm and a positively charged surface with a high zeta potential of 27 mV. Consequently, the ssCP-MSNs showed an excellent binding capacity for siRNA, and an enhancement in the cell uptake and cytosolic availability of siRNA. Furthermore, the intracellular reducing cleavage of the disulfide bonds cross-linking the PDMAEMA segments led to intracellular cleavage of PDMAEMA from ssCP-MSNs, which facilitated the intracellular triggered release of siRNA. Therefore, promoted RNA interference was observed in HeLa-Luc cells, which was equal to that of Lipofectamine 2000. Significantly, compared to Lipofectamine 2000, the ssCP-MSNs were more biocompatible, with low cytotoxicity (even non-cytotoxicity) and promotion of cell proliferation to HeLa-Luc cells. The in vivo systemic distribution studies certified that ssCP-MSNs/siRNA could prolong the duration of siRNA in vivo, and that they accumulated in the adrenal gland, liver, lung, spleen, kidney, heart and thymus after intravenous injection. Encouragingly, with the ability to deliver siRNA to a tumor, ssCP-MSNs/siRNA showed a tumor suppression effect in the HeLa-Luc xenograft murine model after intravenous injection. Therefore, the ssCP-MSNs cationic polymer-mesoporous silica nanoparticles with low cytotoxicity are promising for siRNA delivery.

esiRNAs purified with chromatography suppress homologous gene expression with high efficiency and specificity

A Polyacrylamide Microbead-Integrated Chip for the Large-Scale Manufacture of Ready-to-use Esirna

Short Rna Duplexes Produced By Hydrolysis With Escherichia Coli Rnase Iii Mediate Effective Rna Interference In Mammalian Cells

A Magnetic Bead-Integrated Chip for the Large Scale Manufacture of Normalized Esirnas.

Milligram scale production of potent recombinant small interfering RNAs in Escherichia coli

Ribozyme-enhanced single-stranded Ago2-processed interfering RNA triggers efficient gene silencing with fewer off-target effects

EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs.

Rna Interference Against Hepatitis B Virus with Endoribonuclease-Prepared Sirna Despite of the Target Sequence Variations

A General Approach to High-Yield Biosynthesis of Chimeric Rnas Bearing Various Types of Functional Small Rnas for Broad Applications

A Novel in Vitro Transcription Method for Producing Sirnas Without Specific Sequence Requirements

Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.

Cost-effective Method of Sirna Preparation and Its Application to Inhibit Hepatitis B Virus Replication in HepG2 Cells.

In vivo self-assembled small RNAs as a new generation of RNAi therapeutics

Gene silencing in mammalian cells by PCR-based short hairpin RNA.

Small interfering RNA for experimental cancer therapy.

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

Mesoporous Silica Particle as an RNA Adsorbent for Facile Purification of In Vitro-Transcribed RNA

Prolonged siRNA expression in mammalian cells using an Epstein–Barr virus-based plasmid expression system

N‐Alkyl‐PEI‐Functionalized Iron Oxide Nanoclusters for Efficient Sirna Delivery

Construction of siRNA/miRNA expression vectors based on a one-step PCR process

High Doses of Sirnas Induce Eri-1 and Adar-1 Gene Expression and Reduce the Efficiency of RNA Interference in the Mouse